Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 12, No. 3
March 2006

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



The Case
Conclusions
Acknowledgments
References
Figure
Table 1
Table 2

Dispatch

Lagos Bat Virus, South Africa

Wanda Markotter,* Jenny Randles,† Charles E. Rupprecht,‡ Claude T. Sabeta,§ Peter J. Taylor,¶ Alex I. Wandeler,# and Louis H. Nel*Comments
*University of Pretoria, Pretoria, South Africa; †Allerton Veterinary Laboratory, Pietermaritzburg, South Africa; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; §Onderstepoort Veterinary Research Institute, Pretoria, South Africa; ¶Natural Science Museum, Durban, South Africa; and #Canadian Food Inspection Agency, Nepean, Ontario, Canada

Suggested citation for this article


Three more isolates of Lagos bat virus were recently recovered from fruit bats in South Africa after an apparent absence of this virus for 13 years. The sporadic occurrence of cases is likely due to inadequate surveillance programs for lyssavirus infections among bat populations in Africa.

Since 2003, we have embarked on a passive surveillance study to collect and identify bats with neurologic disease signs that may indicate encephalitis due to lyssavirus infection. Consequently, 3 new cases of Lagos bat virus (LBV) infection in fruit bats were identified in South Africa, 1 each in 2003, 2004, and 2005. LBV is a member of the Lyssavirus genus in the Rhabdoviridae family. Rabies virus (RABV) was first isolated as a unique virus within this group. However, after the isolation of rabies-related viruses in Africa and Europe in the mid-1950s, the Lyssavirus genus was created, and rabies virus (genotype 1) was designated as the type-species member of the genus. At least 7 different major Lyssavirus species (genotypes) are recognized (1), but the genus will be expanded to include organisms isolated from Eurasia in recent years (2). At present, 4 Lyssavirus species (genotypes) are recognized in Africa. Of these, RABV (genotype 1) occurs worldwide, but LBV (genotype 2), Mokola virus (genotype 3), and Duvenhage virus (genotype 4) have not been encountered outside of Africa. Although RABV infection of bats is well known in the Americas, this virus has only been associated with infections of terrestrial mammals on the African continent. Mokola virus has also been isolated only from various terrestrial species, never bats (3). Both LBV and Duvenhage virus are thought to be bat viruses, although LBV infections of terrestrial animals have been reported (4,5). RABV is a zoonotic agent throughout Africa; Duvenhage virus and Mokola virus, but not LBV, have also been responsible for rare zoonotic events (3,6).

LBV was first isolated from a fruit bat in 1956 in Nigeria (7), but not until 1970 was it identified as a rabies-related virus (8). Since then (and before this report), 11 more isolations of LBV were made throughout Africa (Table 1), including 5 isolates from South Africa.

The Case

In June 2003, an Epomophorus wahlbergi carcass was recovered in Durban, KwaZulu-Natal, after the bat was caught by a domestic cat. In August 2004, a resident of Umbilo, Durban, found a dead E. wahlbergi fruit bat on her lawn one morning after hearing squeaking noises around the house during the night. The fluorescent-antibody test (FAT), performed on brain material, was positive for lyssavirus antigens, and virus was isolated in both cases when suckling mice died 9–14 days after intracerebral injection with brain suspensions. Antigenic typing was carried out with a panel of anti-lyssavirus nucleocapsid monoclonal antibodies (prepared by the Centre of Expertise for Rabies, Canadian Food Inspection Agency, Nepean, Ontario, Canada). These analyses identified both new isolates as LBV (genotype 2) (Table 2). Additional characterization was accomplished by polymerase chain reaction (PCR) and sequencing of a 457-bp region of the nucleoprotein-encoding gene with a novel set of PCR and sequencing primers specific for LBV (LagNF (5´-GGGCAGATATGACGCGAGA-3´) and LagNR (5´-TTGACCGGGTTCAAACATC-3´). Briefly, total RNA was extracted from infected tissue by using TRIzol (Invitrogen, Croningen, the Netherlands) according to the manufacturer's instructions. Complementary DNA was produced by a reverse transcription reaction (RT) and used in subsequent PCR. PCR products were purified by using the Wizard SV PCR and Gel purification kit (Promega, Madison, WI, USA). The purified products were then sequenced by using the Big Dye Termination Cycle Sequencing Ready Reaction Kit 3.1 (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's protocol, with subsequent analysis on an Applied Biosystems 377 DNA automated sequencer.

In June 2005, a caretaker/gardener at a communal outdoor sports complex in the Bluff, Durban, found a bat on the lawns of the complex. At the time, birds were picking at it, and on closer inspection, it was found to be an immobile adult animal with a pup attached to it. The caretaker collected both bats and placed them in a nearby tree. Later, the bats, still attached to each other, were again found on the ground, where eyewitnesses also saw a cat toying with it. The animals were then presented to a local bat rehabilitator. The adult animal died and was submitted for diagnostic testing, but results of FAT carried out on brain smears were repeatedly negative. The pup had at least 1 evident bite wound, presumably from the cat, but otherwise appeared healthy and was cared for by the rehabilitator. Although the pup was reported to be feeding and doing well, it suddenly died ≈4 days after being found, on June 21, 2005. By this time, RT-PCR and nucleotide sequencing assays, carried out as described above, showed LBV in brain material from the adult. Antigenic typing was not performed because the level of lyssavirus antigen in the brain matter was undetectable. In the meantime, the carcass of the pup was recovered, and brain material was subjected to FAT and diagnostic RT-PCR. Although the RT-PCR results were inconclusive, the FAT results were negative.

Figure
Figure.

Click to view enlarged image

Figure. A neighbor-joining tree comparing 457 nucleotides of the nucleoprotein-encoding genes of the new Lagos bat isolations...

DNA sequencing information from each case was compared with nucleoprotein sequence information for LBV and other lyssavirus species (genotypes) available in the public domain (GenBank). ClustalW was used to produce sequence alignments and generate a phylogenetic tree (Figure). A graphic representation of the trees was constructed with the TreeView program. In this phylogeny, the 3 new LBV isolates segregate together with previously identified LBV isolates from Ethiopia (AY333110) (7) and Nigeria (U22842) (5). The recent isolates from South Africa share a close sequence homology with the isolate from Ethiopia. This finding warrants further investigation.

Conclusions

Although LBV is rare and has not been reported in South Africa in 13 years, a small-scale passive surveillance effort in KwaZulu-Natal, South Africa, enabled us to identify 3 new isolations of LBV in a relatively short time. This finding reemphasizes our lack of understanding of the true prevalence of lyssaviruses in Africa because of poor surveillance for non-rabies viruses (and, in fact, RABV) throughout the continent. Human infections with LBV have not been documented to date; however, this virus has been reported in domestic animals (2 cats [4] and a dog [5]). We describe close contact between humans and other animals and LBV-infected bats. Cross-neutralization data obtained in rodent models show that rabies preexposure and postexposure prophylaxis is unlikely to be effective against LBV (14). We have shown that LBV infection may be present in bat populations; consequently, we recommend appropriate precautions and use of proper personal protection equipment, such as gloves, when interacting with these animals. Even though the value of rabies vaccination is doubtful, it should be considered in light of the potential for cross-reactivity (15) and the lack of alternatives. Surveillance should be maintained as part of a strategy to better understand the epidemiology of LBV. Cumulatively, all available evidence indicates that LBV is likely persistently maintained in Megachiroptera populations in South Africa and other African countries where LBV has been reported in the past.

Acknowledgments

We thank the members of the bat interest group of KwaZulu-Natal for their interest in this project and for submitting samples.

This work was funded by the National Research Foundation of South Africa.

Ms Markotter is a junior lecturer in microbiology at the University of Pretoria. She is conducting research toward a PhD thesis dealing with the epidemiology and pathogenesis of African lyssaviruses.

References

  1. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. Virus taxonomy: the classification and nomenclature of viruses. The eighth report of the International Committee on Taxonomy of Viruses. San Diego: Academic Press; 2004. p. 623–31.
  2. Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssaviruses genotype definition. Virus Res. 2005;111:28–43.
  3. Nel L, Jacobs J, Jaftha J, von Teichman B, Bingham J. New cases of Mokola virus infection in South Africa: a genotypic comparison of southern African virus isolates. Virus Genes. 2000;20:103–6.
  4. King A, Crick J. Rabies-related viruses. In: Campbell JB, Charlton KM, editors. Rabies. Boston: Kluwer Academic Publishers; 1988. p. 177–200.
  5. Mebatsion T, Cox JH, Frost JW. Isolation and characterization of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: identification of 2 isolates as Mokola and Lagos bat viruses. J Infect Dis. 1992;166:972–7.
  6. Swanepoel R, Barnard BJH, Meredith CD, Bishop GC, Bruckner GK, Foggin CM, et al. Rabies in southern Africa. Onderstepoort J Vet Res. 1993;60:325–46.
  7. Boulger LR, Porterfield JS. Isolation of a virus from Nigerian fruit bats. Trans R Soc Trop Med Hyg. 1958;52:421–4.
  8. Shope RE, Murphy FA, Harrison AK, Causey OR, Kemp GE, Simpson DIH, et al. Two African viruses serologically and morphologically related to rabies virus. J Virol. 1970;6:690–2.
  9. Sureau P, Tignor GH, Smith AL. Antigenic characterization of the Bangui strain (ANCB-672D) of Lagos bat virus. Ann Virol. 1980;131:25–32.
  10. Meredith CD, Standing E. Lagos bat virus in South Africa. Lancet. 1981;1:832–3.
  11. Crick J, Tignor GH, Moreno K. A new isolate of Lagos bat virus from the Republic of South Africa. Trans R Soc Trop Med Hyg. 1982;76:211–3.
  12. Isolations of Lagos bat virus in West Africa. Internal reports of Centre Collaborateur OMS de Reference et Recherche Pour les Arbovirus. Dakar (Senegal): Institut Pasteur; 1985. Available from http://www.pasteur.fr/recherche/banques/CRORA/bibref/br01600.htm and http://www.pasteur.fr/recherche/banques/CRORA/bibref/br01610.htm
  13. Aubert FA. Rabies in individual countries: France. Rabies Bulletin Europe [serial on the Internet].1999 [cited 30 Jan 2006]. Available from http://www.who-rabies-bulletin.org/q2_1999/frame2_99.html
  14. Badrane H, Bahloul C, Perrin P, Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol. 2001;75:3268–76.
  15. Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 2005;111:44–54.

 

Table 1. Lagos bat virus isolates recorded to date


Geographic origin

Year of isolation

Animal

Reference


Lagos, Nigeria

1956

Bat (Eidolon helvum)

(7)

Bozo, Central African Republic

1974

Bat (Micropterus pusillus)

(9)

Pinetown, South Africa (3 isolates)

1980

Bat (Epomophorus wahlbergi)

(10,11)

Stanger, South Africa

1982

Cat

(11)

Kindia, Senegal

1985

Bat (Nycteris cambiensis)

(12)

Dakar, Senegal

1985

Bat (E. helvum)

(12)

Dorowa, Zimbabwe

1986

Cat

(4)

Durban, South Africa

1990

Bat (E. wahlbergi)

(6)

Ethiopia

Before 1992

Dog

(5)

Egypt

1999

Bat (Roussetus aegyptiacus)

(13)

Durban, South Africa

2003

Bat (E. wahlbergi)

This report

Durban, South Africa

2004

Bat (E. wahlbergi)

This report

Durban, South Africa

2005

Bat (E. wahlbergi)

This report


 

Table 2. Immunofluorescence reaction of a panel of 16 monoclonal antibodies against the nucleoprotein of Lagos bat virus isolations, South Africa, 2003 and 2004*


Antibody

Canid biotype (GT1)

Mongoose biotype (GT1)

Lagos bat virus (GT2)

Mokola virus (GT3)

Duvenhage virus (GT4)

2003 isolate

2004 isolate


1C5

26AB7

+++

Variable

26BE2

+++

Variable

32GD12

Variable

Variable

38HF2

+++

+++

+++

+++

+++

+++

+++

M612

+++

+++

+++

M837

+++

M850

Variable

+++

M853

+++

+++

M1001

+++

M1335

Variable

Variable

M1386

+++

M1400

Variable

M1407

++

Variable

M1412

++

Variable

M1494

Variable

+++


*Typical immunofluorescence antibody pattern observed for all lyssavirus genotypes present on the African continent (genotype [GT] 1, 2, 3, and 4) are also included as a reference: –, no specific fluorescence; ++, strong fluorescence; +++, very strong fluorescence.

 

Suggested citation for this article:
Markotter W, Randles J, Rupprecht CE, Sabeta CT, Taylor PJ, Wandeler AI, et al. Lagos bat virus, South Africa. Emerg Infect Dis [serial on the Internet]. 2006 Mar [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol12no03/05-1306.htm

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Louis H. Nel, Faculty of Natural and Agricultural Sciences, Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, South Africa; fax: 012-420-3266; email: louis.nel@up.ac.za

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted February 23, 2006
This page last reviewed February 24, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention